LIF and lung cancer: In contrast, miR-500a-3p was significantly associated with longer survival of lung cancer patients and targeted two cancer-associated genes, LIF (leukemia inhibitory factor) and PAPPA (pregnancy-associated plasma protein A, pappalysin 1).